IDiyas

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Marco Gottardis

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 313(Granted Patents)


Company Filing History:

goldMedal14 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
silverMedal6 out of 2,076 
 
Janssen Pharmaceutica Nv
 patents
bronzeMedal1 out of 410 
 
Janssen Biotech, Inc.
 patents
4. 1 out of 832,680 
Other
 patents

Years Active: 2003-2025

Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents
1. 12383543 - Methods of treating prostate cancer (2025-08-12),
2. 11992486 - Methods of treating prostate cancer (2024-05-28),
3. 11986470 - Methods of treating prostate cancer (2024-05-21),
4. 11986469 - Methods of treating prostate cancer (2024-05-21),
5. 11986468 - Methods of treating prostate cancer (2024-05-21),
6. 11793843 - Prostate neoantigens and their uses (2023-10-24),
7. 11207311 - Method of treating prostate cancer (2021-12-28),
8. 10954286 - Bispecific EGFR/IGFIR binding molecules (2021-03-23),
9. 10774130 - Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins (2020-09-15),
10. 10183987 - Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules (2019-01-22),
11. 9902762 - Multivalent fibronectin based scaffold domain proteins (2018-02-27),
12. 9771411 - Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules (2017-09-26),
13. 9017655 - Bispecific EGFR/IGFIR binding molecules (2015-04-28),
14. 8728483 - Multivalent fibronectin based scaffold domain proteins (2014-05-20),
15. 8492328 - Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators (2013-07-23),

Title: Marco Gottardis: A Pioneer in Prostate Cancer Treatment

Introduction

Marco Gottardis, based in Princeton, NJ, has made significant contributions to the field of cancer research, particularly in the treatment of prostate cancer. With an impressive portfolio of 21 patents to his name, his innovations have the potential to impact the lives of many patients.

Latest Patents

Among his latest patents, Gottardis has disclosed methods of treating prostate cancer by administering niraparib to humans in need. This innovative approach signifies a crucial step forward in targeted cancer therapies, showcasing the potential for improved patient outcomes through his research.

Career Highlights

Throughout his career, Marco Gottardis has worked with leading pharmaceutical companies, including Bristol-Myers Squibb Company and Janssen Pharmaceutica NV. His extensive experience in these organizations has allowed him to develop and refine innovative treatments that address critical medical needs.

Collaborations

Gottardis has collaborated with esteemed colleagues such as Joan Carboni and Ray Camphausen. Their combined expertise in oncology and pharmaceutical sciences has fostered an environment of innovation and advancement in cancer treatment methodologies.

Conclusion

Marco Gottardis stands out as a prominent inventor in the medical field, particularly in his groundbreaking research on prostate cancer therapies. His ongoing contributions through patents and collaborations reflect his commitment to advancing cancer treatment and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…